Sarcomatoid renal cell carcinoma: An examination of underlying histologic subtype and an analysis of associations with patient outcome
Cheville JC, Lohse CM, Zincke H et al. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004; 28: 435-41.
Sarcomatoid differentiation in renal cell carcinoma: A study of 101 cases
de Peralta-Venturina M, Moch H, Amin M et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 2001; 25: 275-84.
C-kit expression in sarcomatoid renal cell carcinoma: Potential therapy with imatinib
Castillo M, Petit A, Mellado B, Palacin A, Alcover JB, Mallofre C. C-kit expression in sarcomatoid renal cell carcinoma: potential therapy with imatinib. J Urol 2004; 171(6 Pt 1): 2176-80.
(2004)J Urol, vol.171, Issue.6 PART 1, pp. 2176-2180
Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma
Kang DE, White RL Jr, Zuger JH, Sasser HC, Teigland CM. Clinical use of fluorodeoxyglucose F 18 positron emission tomography for detection of renal cell carcinoma. J Urol 2004; 171: 1806-9.
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma
Ramdave S, Thomas GW, Berlangieri SU et al. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol 2001; 166: 825-830.